Session Information
AABB Annual Meeting & CTTXPO 2011
Click here to go to the previous page
Red Blood Cells: Immunohematology, Molecular Testing and Genetics, Serology and Genetics
Track
:
Oral Abstracts
Program Code:
040B
Date:
Tuesday, October 25, 2011
Time:
2:00 PM to 3:30 PM
PST
Location:
28 C/D
MODERATOR
(S):
Gregory Denomme, PhD, FCSMLS(D), Director of Immunohematology & Transfusion Services, BloodCenter of Wisconsin
Dr. Margaret Keller, PhD, Director, National Molecular Laboratory, American Red Cross
- To assess the feasibility and diagnostic accuracy of fetal RhD detection in maternal plasma.
- To describe how to establish rapid molecular blood group typing and apply it to the management of sickle cell anemia patients.
- To recognize that patients with the weak D phenotype are at risk of producing anti-D.
| CE Category | CE Value |
|---|---|
| California Clinical Laboratory Personnel | 1.5 |
| California Nurse | 1.8 |
| Florida Laboratory Personnel | 1.8 |
| General Attendee | 1.5 |
| Physician | 1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.
This session is a part of:
 | Copyright © 2014 by MultiView, Inc. All website graphics, text, design, software, and other works are the copyrighted works of MultiView, Inc. All audio, video, presentation materials, logos and text are the copyrighted works of their respective owners. All Rights Reserved. Any redistribution or reproduction of any materials herein is strictly prohibited. |  |